Abstract
Bone involvement is a common finding in Cushing’s syndrome. The actions of corticosteroids on bone have been studied quite intensively but only a few studies of bone histomorphometry in this syndrome have been published. In this paper we present histomorphometric measurements of bone activity in 7 patients with a postoperative reevaluation in two. The results show irregular alterations on histomorphometric parameters with an increased bone resorption and decreased bone formation rate. After surgery the abnormalities changed towards normal.
Similar content being viewed by others
References
Cushing H. The basophil adenomas of the pituitary body their clinical manifestations (pituitary basophilism) Bull. Johns Hopkins Hosp. 50:137, 1932.
Meunier P.J., Dempster D.W., Edouard C., Chapuy M.C., Arlot M., Charhon S. Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing’s syndrome. Adv. Exp. Med. Biol. 171:191, 1984.
Pocock N.A., Eisman J.A., Dunstan C.R., Evans R., Thomas D.H., Huq N.L. Recovery from steroid-induced osteoporosis. Ann. Intern. Med. 107:319, 1987.
Bressot C., Meunier P.J., Chapuy M.C., Lejeune E., Edouard C., Darby A.J. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab. Bone Dis. Rel. Res. 1:303, 1979.
Bressot C., Courpron P., Edouard C., Meunier P.J. La maladie de Cushing. In: Association Corporative des Etudiants en Medecine de Lyon (Ed.), Histomorphometrie des Osteopathies Endocriennes. 1976, pp. 139–151.
Gallagher J.C., Aaron J., Horsman A., Wilkinson R., Nordin B.E.C. Corticosteroid osteoporosis. Clin. Endocrinol. Metab. 2:355, 1973.
Caniggia A., Nuti R., Lore F., Vattimo A. Pathophysiology of the adverse effects of glucoactive corticosteroid on calcium metabolism in man. J. Steroid Biochem. 15:153, 1981.
Gennari C., Imbimbo B., Montagnani M., Bernini M., Nardi P., Avioli L.V. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif.Tissue. Int. 36:245, 1984.
Baylink D.J. Glucocorticoid-induced osteoporosis. N. Engl. J. Med. 309:306, 1983.
Avioli L.V. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption. Adv. Exp. Med. Biol. 171:81, 1984.
Hahn T.J. Drug induced disorders of vitamin D and mineral metabolism. Clin. Endocrinol. Metab. 9:107, 1980.
Raisz L.G., Chyun Y.S. Glucocorticoids and bone matrix formation. Adv. Exp. Med. Biol. 171:131, 1984.
Baron R., Vignery A., Neff L., Silverglate A.S., Santa-Maria A. Processing of uncalcified bone specimens for bone histomorphometry. In: Recker R.R.(Ed.), Bone histomorphometry techniques and interpretation. CRC Press, 1983, p 13.
Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Histomorphometry: standardization of nomenclature, symbols and units. J. Bone Min. Res. 2:595, 1987.
Bessey O., Lowry O.H., Brock M.J. A method for the rapid determination of alkaline phosphatase with five milliliters of serum. J. Biol. Chem. 164:321, 1946.
Fiske C.H., Subbarow Y. Colorimetric determination of phosphorus. J. Biol. Chem. 66:375, 1925.
Greenwald I. The chemistry of Jaffe’s reaction for creatinine. J. Biol. Chem. 60:103, 1928.
Meunier P.J. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease. J. Bone Min. Res. 6:259, 1988.
Melsen F., Mosekilde L. Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif. Tissue. Res. 26:99, 1978.
Chavassieux P.M., Arlot E.M., Meunier P.J. Intersample variation in bone histomorphometry: - comparison between parameter values measured in two continuous transiliac bone biopsies. Calcif. Tissue. Int. 37:345, 1985.
Frost H.M., Villanueva A.R. The effect of cortisone on lamellar osteoblastic activity. Henry Ford Hosp. Med: Bull. 9:97, 1961.
Jowsey J., Riggs B.L. Bone formation in hypercortisonism. Acta Endocrinol (Copenh.) 66:21, 1970.
Lund B., Storm T.L., Lund B., Nilsen F., Mosekilde L., Andersen R.B., Egmose C., Sorensen D.H. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long term glucocorticoid treatment. Clin. Rheumatol. 4:143, 1985.
Stellion A.J., Davies A., Compston J., Willians R. Bone loss in autoimmune chronic hepatitis on maintenance corticosteroid therapy. Gastroenterology 89:1078, 1985.
Hahn T.J., Halstead L.R., Teitelbaum S.L., Hahn B.H. Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J. Clin. Invest. 64:655, 1979.
Raisz, L.G., Trummel C.L., Wener J.A., Simmons H. Effects of glucocorticoids on bone resorption in tissue culture. Endocrinology 96:961, 1972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borelli, A., Leite, M.O.R., Correa, P.H.S. et al. Bone histomorphometry in Cushing’s syndrome. J Endocrinol Invest 15, 783–787 (1992). https://doi.org/10.1007/BF03348804
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348804